Jason Bouvier
Stock Analyst at Scotiabank
(1.53)
# 3,268
Out of 4,876 analysts
9
Total ratings
33.33%
Success rate
1.74%
Average return
Main Sectors:
Stocks Rated by Jason Bouvier
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
OVV Ovintiv | Maintains: Sector Outperform | $50 → $53 | $38.41 | +37.98% | 3 | Nov 18, 2024 | |
IMO Imperial Oil | Downgrades: Sector Perform | $110 | $79.35 | +38.63% | 2 | Sep 25, 2024 | |
SU Suncor Energy | Maintains: Sector Perform | $61 → $60 | $37.59 | +59.62% | 1 | Jul 12, 2024 | |
CVE Cenovus Energy | Maintains: Sector Outperform | $35 → $34 | $13.65 | +149.08% | 1 | Jul 12, 2024 | |
CNQ Canadian Natural Resources | Maintains: Sector Perform | $114 → $57 | $31.45 | +81.24% | 1 | Jun 11, 2024 | |
IKNA Ikena Oncology | Initiates: Buy | n/a | $1.36 | - | 1 | Apr 20, 2021 |
Ovintiv
Nov 18, 2024
Maintains: Sector Outperform
Price Target: $50 → $53
Current: $38.41
Upside: +37.98%
Imperial Oil
Sep 25, 2024
Downgrades: Sector Perform
Price Target: $110
Current: $79.35
Upside: +38.63%
Suncor Energy
Jul 12, 2024
Maintains: Sector Perform
Price Target: $61 → $60
Current: $37.59
Upside: +59.62%
Cenovus Energy
Jul 12, 2024
Maintains: Sector Outperform
Price Target: $35 → $34
Current: $13.65
Upside: +149.08%
Canadian Natural Resources
Jun 11, 2024
Maintains: Sector Perform
Price Target: $114 → $57
Current: $31.45
Upside: +81.24%
Ikena Oncology
Apr 20, 2021
Initiates: Buy
Price Target: n/a
Current: $1.36
Upside: -